The FDA on Wednesday opened a new era in cancer treatment, when it approved a landmark, futuristic new gene therapy-based approach to treat childhood leukemia, one which has produced unprecedented results in patients with the deadly cancer. Even the FDA called the approval "historic."

"We're entering a new frontier in medical innovation with the ability to reprogram a patient's own cells to attack a deadly cancer," said FDA Commissioner Scott Gottlieb.

The CAR-T cell treatment, developed by Novartis and the University of Pennsylvania, is the first  http://www.zerohedge.com/news/2017-08-30/fda-approves-futuristic-ne...